Our analysis of the association of ALDH1A1 RNA expression levels with recurrent AML leads to the suggestion that ALDH1A1 is involved in AML cell resistance to chemotherapy, potentially through the reduction of oxidative stress [18] and the survival of ALDH1A1-expressing leukemia stem cells. The gene discussed is ALDH1A1; the disease is acute myeloid leukemia.